I-Pharm Consulting Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
I-Pharm Consulting Limited - overview
Established
2008
Location
London, -, UK
Primary Industry
Outsourcing
About
Based in London, UK and founded in 2008, I-Pharm Consulting Limited operates as a talent solutions provider for the life sciences sector. It offers permanent recruitment, contract recruitment, executive search and GxP consulting services across areas like drug development, biometrics, clinical research, commercial, medical & scientific, assurance, regulatory affairs and medtech. It provides tailored talent solutions to pharmaceutical, biotech and medtech companies globally.
Primary Industry
Outsourcing
Sub Industries
Outsourcing, Recruitment/Executive Search
Website
http://www.i-pharmconsulting.com
Total Amount Raised
Subscriber access only
I-Pharm Consulting Limited - financials
| Fiscal Year Ended | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|---|---|---|
| Revenue (USD) | 9,596,574 | 10,147,912 | 11,236,804 | - | - | - |
| % Revenue Growth (YoY) | - | 5.7% | 10.7% | - | - | - |
| EBITDA (USD) | 369,937 | 296,607 | 457,765 | - | - | - |
| Operating Income (USD) | 369,937 | 296,607 | 457,765 | - | - | - |
| Operating Margin | 3.9% | 2.9% | 4.1% | - | - | - |
| % EBITDA Margin | 3.9% | 2.9% | 4.1% | - | - | - |
| NET Income (USD) | 309,916 | 205,402 | 352,580 | - | - | - |
| % Net Margin | 3.2% | 2.0% | 3.1% | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.